 |
Principal
Investigator: Stimson
Schantz,
M.D.
Objective:
To demonstrate that abnormal estrogen
metabolites are a risk factor for thyroid goiter in a case-control
epidemiologic study.
Overview:
The development of the common problem of
thyroid enlargement, goiter, may be secondary to abnormal estrogen
metabolites. These metabolites may stimulate the thyroid gland to become
enlarged and lead to patient morbidity. This study assesses for the
presence of abnormal estrogen metabolite in patients with thyroid goiter
and healthy controls in a case-control analysis. Co-Investigators are
Edwin Chan, MD, Helen Yoo, MD and Guopei Yu, MD, MPH.Contact
Information: Edwin Chan, M.D., (212)
979-4200
|